| CXSS2300016 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(2.2) | New Drug Application | 2023-04-05 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CYSB2200223 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(1) | Supplementary Application | 2022-09-07 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CXSS2200077 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(2.2) | New Drug Application | 2022-09-08 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CXSS2300007 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(2.2) | New Drug Application | 2023-02-28 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CXSS2101026 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(1) | New Drug Application | 2021-09-06 | | Wuxi Biologics Co Ltd;Cornerstone Pharmaceutical (Suzhou) Co Ltd | | | view |
| CYSB2300028 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products | Supplementary Application | 2023-02-04 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CYSB2200232 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(1) | Supplementary Application | 2022-09-22 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CYSB2500115 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(1) | Supplementary Application | 2025-05-21 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CYSB2300013 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Wuxi Biologics Co Ltd;Pfizer Investment Co Ltd | | | view |
| CXSS2000056 | 舒格利单抗注射液 | Sugemalimab | Injection | Biological Products(1) | New Drug Application | 2020-11-13 | 基石药业（苏州）有限公司,无锡药明生物技术股份有限公司 | Wuxi Biologics Co Ltd;Cornerstone Pharmaceutical (Suzhou) Co Ltd | Approval Completed-Pending Certificated | 2021-12-20 | view |
